Manuela Berto Pucca

She holds a degree in Biomedicine (2004 - CRBM-4:7332 active), specializing in Clinical Pathology / Clinical Analyses (2007), with a Master's (2009) and a Ph.D. (2012 - including a sandwich period abroad at KULeuven, Belgium) in Immunology from the Department of Biochemistry and Immunology, Ribeirão Preto Medical School - University of São Paulo - USP (CAPES 7). She completed two post-doctorates: one at the Ribeirão Preto School of Pharmaceutical Sciences - University of São Paulo - USP (FAPESP scholarship 2012/12954-6 with a one-year period at Katholieke Universiteit Leuven (KUL) in Leuven - Belgium (BEPE scholarship 2013/21329-0); and another at the Technical University of Denmark (DTU) in Lyngby, Denmark. She was an adjunct professor in the Medicine program (area: Immunology) at the Federal University of Roraima - UFRR (2016-2023). She is an assistant professor MS 3.1 in the Department of Clinical Analyses at the School of Pharmaceutical Sciences of São Paulo State University (UNESP) in Araraquara and is in charge of the Immunology and Toxinology Laboratory - ITox-Lab. She has 90 articles published in internationally recognized journals (Google Scholar: H-factor=25, i10=40, 1825 citations). She holds a patent granted by INPI - Serrumab (BR102013005043-1). She is an inventor/collaborator on several human monoclonal antibodies with potential biotechnological application and therapeutic use (biotherapeutics: Serrumab, Afribumab, Bothrumab, Lachesumab, and Cro-Botrumabs) and other technological products. She has participated in over 80 National and International Events (Switzerland, Spain, England, United States, Turkey, China, Sweden, Denmark, Costa Rica, Netherlands, Canada, and the United Arab Emirates), as well as organizing courses, workshops, congresses, and webinars. She acts as a reviewer for journals such as Toxins, Toxicon, Acta Tropica, Peptides, Immunopharmacology and Immunotoxicology, Journal of Proteomics, Scientific Reports (Nature), Journal of Venomous Animals inc. Tropical Diseases, Antibodies, PlosOne, Vaccines, Frontiers in Immunology/Medicine/Pharmacology/Tropical Diseases, Venoms and Toxins, Biochemical and Biophysical Acta, Journal of Asthma and Allergy, among others. She is a member of the editorial board of Frontiers, Toxicon, Toxicon-X, and Toxins. She was a full member of the Research and Development Activities Committee in the Amazon (CAPDA-SUFRAMA). She is a lecturer and advisor for the Professional Master's Program in Health Sciences - PROCISA, the Postgraduate Program in Tropical Medicine PPGMT of UEA/FMT-HVD, and the Postgraduate Program in Biosciences and Biotechnology Applied to Pharmacy (BBAF-UNESP). She is an associated researcher at the TRANSLATIONAL SCIENCE CENTER AND BIO-PHARMACEUTICAL DEVELOPMENT-FAPESP and a researcher at the Center for Venoms and Venomous Animals Studies at UNESP (CEVAP-UNESP). She is a productivity assessor and scholarship recipient (DT2) from CNPQ, working in the evaluation of scientific initiation projects, papers, and programs (PIBIC/PIBITI). She is an ad hoc assessor for CAPES, CNPQ, and the MRC (Medical Research Council). She participated in the creation of the startup Zeta Venom, accelerated by programs such as INOVA AMAZÔNIA, CATALISA ICT, Like a Boss, SOSA - Land to Launch, Mulheres Empreendedoras-FINEP, and others. She has experience in innovation and works in the development of pharmaceutical products. She has received several awards and honorable mentions, notably the "Pride of Roraima" commendation for her high scientific production in the state (2022), the ALUMNI USP award (2022) for USP alumni (quality of life category), and the VENOM GREAT CONTRIBUTION AWARD (2022). She is the coordinator of the Venom Talks Extension Project and co-coordinator of Snakebite Roraima. She has extensive experience in toxinology, tropical neglected diseases, basic and clinical immunology, biotherapeutics, and innovation. She conducts scientific research in the Amazon, includ (Source: Lattes Curriculum)